IPXL
Impax Laboratories, Inc.
IPXL
IPXL
Delisted
IPXL was delisted on the 4th of May, 2018.
178 hedge funds and large institutions have $792M invested in Impax Laboratories, Inc. in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 75 increasing their positions, 47 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
178
Holders Change
-20
Holders Change %
-10.1%
% of All Funds
4.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
31
Increased
75
Reduced
47
Closed
44
Calls
$2.75M
Puts
$1.93M
Net Calls
+$823K
Net Calls Change
+$1.46M
Top Buyers
| 1 |
BlackRock
New York
|
+$137M |
| 2 |
Millennium Management
New York
|
+$27.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$19.4M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$14M |
| 5 |
SIG
Senator Investment Group
New York
|
+$13.9M |
Top Sellers
| 1 |
HP
Hound Partners
New York
|
-$58.8M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$28.8M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$16.9M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$16.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$14.1M |
